کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3947190 1254416 2011 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
چکیده انگلیسی

ObjectiveEpithelial ovarian carcinoma (OvCa) is rarely detected early, and it is also difficult to determine whether an adnexal mass is benign or malignant. Previously, we noted differences in methylation patterns of cell-free plasma DNA (cfpDNA) in women without disease compared to patients with OvCa. In this work, we investigated whether methylation patterns of cfpDNA can differentiate between benign and malignant tumors.MethodsMethylation patterns in cfpDNA were determined in three cohorts (30 samples each) using a microarray-based assay (MethDet 56). Principal component analysis, supervised clustering, linear discrimination analysis, and 25 rounds of 5-fold cross-validation were used to determine informative genes and assess the sensitivity and specificity of differentiating between OvCa vs. healthy control (HC), benign ovarian disease (mostly serous cystadenoma, BOD) vs. HC, and OvCa vs. BOD samples.ResultsDifferential methylation of three promoters (RASSF1A, CALCA, and EP300) differentiated between OvCa vs. HC with a sensitivity of 90.0% and a specificity of 86.7%. Three different promoters (BRCA1, CALCA, and CDKN1C) were informative for differentiating between BOD vs. HC, with a sensitivity of 90.0% and a specificity of 76.7%. Finally, two promoters (RASSF1A and PGR-PROX) were informative for differentiating between OvCa vs. BOD, with a sensitivity of 80.0% and a specificity of 73.3%.ConclusionsThis proof-of-principle data show that differential methylation of promoters in cfpDNA may be a useful biomarker to differentiate between certain benign and malignant ovarian tumors.Research Highlights
► Methylation patterns in cell-free DNA from blood can detect ovarian tumors
► These patterns are different in patients with benign and malignant tumors
► Methylation of blood DNA can be used for differential diagnosis of ovarian cancer

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 120, Issue 1, January 2011, Pages 113–120
نویسندگان
, , , , , , , , ,